0001209191-15-027190.txt : 20150317 0001209191-15-027190.hdr.sgml : 20150317 20150317175047 ACCESSION NUMBER: 0001209191-15-027190 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150312 FILED AS OF DATE: 20150317 DATE AS OF CHANGE: 20150317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Popovits Kimberly J CENTRAL INDEX KEY: 0001333482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 15708113 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-03-12 0 0001131324 GENOMIC HEALTH INC GHDX 0001333482 Popovits Kimberly J 301 PENOBSCOT DRIVE REDWOOD CITY CA 94403 1 1 0 0 President and CEO Common Stock 2015-03-12 4 M 0 3000 18.89 A 37939 D Common Stock 2015-03-12 4 S 0 3000 31.9058 D 34939 D Common Stock 2015-02-27 5 G 0 E 500 0.00 D 204101 I Held by the Popovits 2010 Trust Common Stock 2015-02-27 5 G 0 E 500 0.00 D 203601 I Held by the Popovits 2010 Trust Common Stock 2015-02-27 5 G 0 E 100 0.00 D 203501 I Held by the Popovits 2010 Trust Common Stock 2015-02-27 5 G 0 E 500 0.00 D 203001 I Held by the Popovits 2010 Trust Common Stock 12298 I Held by UBS for Benefit of Kimberly Popovits Common Stock 16825 I Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee. Employee Stock Option (right to buy) 18.89 2015-03-12 4 M 0 3000 0.00 D 2016-11-30 Common Stock 3000 18313 D These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 10, 2014. Represents weighted average sale price. Actual sale prices ranged from $31.62 to $32.26. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Includes an aggregate of 12,883 shares of common stock issuable pursuant to previously reported restricted stock units and performance-based vesting restricted stock units awards that have not vested. The option became exercisable as to 25% of the shares on November 30, 2007, and becomes exercisable as to 1/48th of the shares each full month thereafter. /s/ G. Bradley Cole, Attorney-in-fact 2015-03-17